Elon Musk said Thursday that Tesla’s Optimus robots should be available to the public by the end of next year, after the company refines the technology. “That’s when we are confident that its very ...

Mike Macdonald's Seahawks are ready to embrace the role of being the hunted. Thearon W. Henderson / Getty Images SAN FRANCISCO — The morning after the Seattle Seahawks were crowned champions of Super ...

TD Cowen analysts Lance Vitanza and Jonnathan Navarrete said Strategy is “better positioned than ever” to participate in a potential recovery, even as the premise looks strained amid steep declines.

This is read by an automated voice. Please report any issues or inconsistencies here. Canadian Prime Minister Mark Carney says Canada won’t pursue a free trade deal with China, responding to Trump’s ...

Nipah is a zoonotic virus with a high mortality rate Charlotte Phillipp is a Weekend Writer-Reporter at PEOPLE. She has been working at PEOPLE since 2024, and was previously an entertainment reporter ...

The standout feature of the Ninja Crispi Pro is its CleanCrisp Glassware. Made from thermal shock resistant glass, it allows for visible monitoring of the cooking process and provides a non-toxic ...

Centerra Gold reached my target price after benefiting from the gold bull market and multiple expansions. CGAU's Oksut mine is nearing end-of-life, with declining production and rising costs, but ...

Shares of Target climbed Friday after the Financial Times reported that hedge fund Toms Capital Investment Management has made a “significant investment” in the big-box retailer, whose sales and share ...

Driving through the desert, the border appeared and disappeared without warning. No guards, no checkpoint, no questions asked. Flags changed, but daily life didn’t. In a world obsessed with borders, ...

Iran’s president ordered security forces not to target peaceful protesters, a bid to defuse violent unrest that activists say has left at least 36 people dead. “No security action should be taken” ...

Amgen is getting down with Disco Pharmaceuticals, commissioning the German outfit to work on cancer therapies focused on a target the biotech has already identified. Cologne-based Disco has developed ...